EP4119153
CD47 TARGETED THERAPIES FOR THE TREATMENT OF INFECTIOUS DISEASE
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
5.2.2014EP published:
24.4.2024EP application number:
22185801.2
EPO information:
European Patent Register
Max expiry date:
4.2.2034
Title in English:
CD47 TARGETED THERAPIES FOR THE TREATMENT OF INFECTIOUS DISEASELanguage of the patent:
English
Timeline
Today
5.2.2014EP application
24.4.2024EP Publication
Owner
Name:
The Board of Trustees of the Leland Stanford Junior UniversityAddress:
Office of the General Counsel Building 170, Third Floor, Main Quad P.O. Box 20386, Stanford, CA 94305-2038, US
Name:
The United States of America, as represented by the Secretary, Department of Health and Human ServicesAddress:
6011 Executive Boulevard, Suite 325, MSC 7660, Bethesda, MD 20892-7660, US
Name:
The Regents of the University of CaliforniaAddress:
1111 Franklin Street, 12th Floor, Oakland, CA 94607-5200, US
Inventor
Name:
WEISKOPF, KippAddress:
Brookline, 02445, US
Name:
HASENKRUG, Kim J.Address:
Victor, 59875, US
Name:
STODDART, Cheryl A.Address:
Pacifica, 94044, US
Name:
MCCUNE, Joseph M.Address:
San Francisco, 94117, US
Name:
WEISSMAN, Irving L.Address:
Stanford, 94305, US
Priority
Number:
201361761133 PDate:
5.2.2013Country:
US
Classification
Categories:
A61K 38/17, A61K 35/00, C07K 16/28, A61P 31/12